Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal

Home page

RA1 - Characterisation of animal lines

RA1 has as its overall objective to characterise the animal lines of the different species used as experimental models of animal infectious diseases including susceptibility, definition of surrogate markers of infection and evaluation of exposure and manipulation procedures.

Background

Experimental infection in animals has been and is still used as a proof of an organism's disease causing ability. Although many infectious agents show a significant degree of host specificity, causing disease in only a few related species, numerous animal models have now been developed that closely mimic the course of animal and human infectious diseases. These models have been developed because they offer insights into the pathogenicity of the infection and the immune response against the pathogen, and provide a convenient system for testing new diagnostic and therapeutic tools and vaccines. However, animal populations typically exhibit considerable genetic variation for resistance to infection by a selected pathogen. This genetic variability might be used through appropriate QTL or functional genomic methodology to determine genetic mechanisms of susceptibility but may also result in the failure or inconclusiveness of experimental trials.

The use of reference lines with known sanitary and genetic status increases the results’ reliability. When available, the inbred lines stability allows to cumulate data and between experiments comparisons. These advantages have been determinant for the development of mouse models of infection in Biomedical research. But the development of emergent diseases in farm animals and the study of their transmissibility to human require the development of a model of infection directly in the target host or in mice carrying human gene involved in genetic susceptibility to diseases.

Approach

Members of the platform will share animal lines, expertise, and facilities to promote research on these invaluable tools that represent animal lines with a defined sanitary status and genetic characteristics.

  • Definition of sanitary status will be done according to available regulations and using classical immunological and microbiological tools. In addition specific amplification (PCR) of pathogen nucleic acids
  • will be done as required.
  • Genetic characterization and comparisons between lines will use modern tools from the molecular genomics and particularly SNPs markers to define within line and interlines diversity.
  • Disease susceptibility of each line will be investigated through experimental infections and pathogenesis studies that will involve potential pathogens from classical and emerging diseases. In case of inbred lines, researchers will be able to cumulate available information relative to each line.

This will help to the definition of farm animals models of infection adapted to the development and validation of new diagnosis, vaccines, and therapeutics tools. Emerging pathogens to be used in this work programme will be selected by the partners involved (see RA3).

Task leaders

  • RA1.1 – Characterisation of inbred chicken lines
    Task Leader : Institute for Animal Health (United Kingdom)
  • RA1.2 – Characterisation of dd minipigs
    Task leader: Institute for Animal Health IAH United Kingdom
  • RA1.3 – Characterisation of sheep
    Task leader: Moredun Research Institute (United Kingdom)
  • RA1.4 – Characterisation of transgenic mice
    Task leader: Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (Spain)
  • RA1.5 – Characterisation of fishes
    Task Leader: Veterinærmedisinsk oppdragssenter AS (Norway)
  • RA1.6 – Euro immunological tools
    Task leader: Institute for Animal Health IAH United Kingdom